Open Access

RESIDENT’S CORNER

The disappearing PI-RADS 5 prostate lesion

Vikram K. Sabarwal^1,2, Cayde Ritchie³, Kareem Rayn⁴, Baris Turkbey⁵, Peter Pinto²

1 Department of Urology, George Washington University Hospital, Washington, DC, USA
2 Urologic Oncology Branch, National Institute of Health, Bethesda, Maryland, USA
3 Loma Linda University School of Medicine, Loma Linda, California, USA
4 SUNY Downstate College of Medicine, Brooklyn, New York, USA
5 Department of Radiology, National Institute of Health, Bethesda, Maryland, USA
Address correspondence to Dr. Vikram K. Sabarwal, Department of Urology, George Washington University School of Medicine, 2150 Pennsylvania Ave., Suite 3-417, Washington, DC 20037 USA

Canadian Journal of Urology 2018, 25(2), 9281-9283.

Abstract

Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) identifies prostate cancer on the basis of multiparametric MRI (mpMRI). As an assessment tool, it correctly predicts clinically significant cancer in the vast majority of cases. In this light, we report a rare patient, for whom a PI-RADS 5 lesion vanished over the course of 13 months.

---

Keywords

---